The Federal Trade Commission proposed a rule that could lift wages by nearly $300 billion per year economy-wide by making it illegal for companies to block their employees from working for a competitor, The New York Times reported Jan. 5.
Category: ROOT
Mayo Clinic picks up stake in startup making pill-sized robot
Rochester, Minn.-based Mayo Clinic has obtained a stake in Endiatx, a startup making a pill-sized robot to diagnose digestive conditions, under a know-how licensing agreement with the company.
GI Alliance adds 2 leaders to board
GI Alliance, a Southlake, Texas-based GI practice management company, has appointed Kelly Robison and Paul Mango to its board.
4 recent ASC acquisitions, partnerships
Here are four ASC acquisitions and partnerships that Becker’s has reported on since Dec. 1:
Walgreens Boots Alliance reports $3.7B Q1 net loss
Walgreens Boots Alliance reported a $3.7 billion net loss in the first quarter of the 2023 fiscal year ending Nov. 30, a significant drop from $3.6 billion in net income over the same period last year, driven by after-tax charges for opioid-related cla…
Patient shot by off-duty officer in hospital gets $900K
Alan Pean, who was shot in his hospital room by an off-duty police officer during a mental health crisis, won $902,500 in a settlement with the city of Houston, the Texas Observer reported Jan. 4.
New York drops emergency PCI cases from physician-level reports
New York is dropping its emergency percutaneous coronary intervention (PCI) mortality outcomes requirement at the physician level, TCTMD reported Jan. 4.
Kansas hospital reinstates CEO on administrative leave
The Norton (Kan.) County Hospital board of trustees have voted to reinstate CEO Brian Kirk, who was placed on administrative leave in December, a hospital spokesperson confirmed to Becker’s.
Deborah Heart and Lung Center names Dr. Gregory Domer vascular surgery chair
Browns Mills, N.J.-based Deborah Heart and Lung Center named Dr. Gregory Domer chair of vascular surgery.
XBB.1.5's transmissibility, severity: 4 Qs answered
Health officials are keeping a close eye on omicron subvariant XBB.1.5 due to its rapid growth in the U.S.
